Subscribe By E-Mail

Harvard Apparatus withdraws IPO, plans NASDAQ listing via Harvard … – NASDAQ

Harvard Apparatus withdraws IPO, plans NASDAQ listing via Harvard
NASDAQ
Harvard Apparatus Regenerative Technology, a Harvard Bioscience carve-out focusing on regenerative medicine, withdrew its plans for an initial public offering on Thursday citing poor market conditions. Instead, Harvard Bioscience plans to spin off 100
HBIO Reports First Quarter 2013 ResultsGlobeNewswire (press release)

all 6 news articles »

nasdaq – Google News